Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Pre-Open Stock Movers 02/24: (NGM) (NNVC) (A[T) Higher; (EPZM) (AMD) (AAPL) Lower (more...)
-
Epizyme Announces Date of Fourth Quarter and Full Year 2019 Results and Presentations at Upcoming Investor Conferences
-
Epizyme Announces Closing of Concurrent Public Offerings and Full Exercise of Underwriter’s Option to Purchase Additional Shares
-
Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock
-
Epizyme (EPZM) to Offer Common Stock and Preferred Stock
-
Epizyme Announces Proposed Concurrent Public Offerings of Common Stock and Series A Preferred Stock
-
Epizyme Announces Presentations at Upcoming March Investor Conferences
-
Cowen Starts Epizyme (EPZM) at Outperform
-
Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference
-
Epizyme Announces Date of Fourth Quarter and Full Year 2017 Results Conference Call and Upcoming Presentation at the Cowen 38th Annual Health Care Conference
-
Epizyme Announces 2016 Fourth Quarter and Full-Year Results Conference Call Date and March Investor Conferences
-
Epizyme Announces Closing of Common Stock Offering
-
Epizyme (EPZM) 6M Offering Prices at $20.75/Share
-
Epizyme Announces Pricing of Public Offering of Common Stock
-
Epizyme (EPZM) to Offer 4.75M Common Shares
-
Epizyme Announces Proposed Public Offering of Common Stock
-
Epizyme (EPZM) Announces 4.2M Common Stock Offering
-
Notable Analyst Rating Changes 06/25: (MRVL) (LVS) (LRCX) Upgraded; (NFLX) (PAAS) (DMD) Downgraded
-
Cowen Starts Epizyme (EPZM) at Outperform
-
Epizyme (EPZM) Plans to Sell 4.29M Common in IPO
-
Epizyme (EPZM) Files $69M IPO

